Sio Gene Therapies Inc. Quarterly Current Ratio in % from Q4 2015 to Q4 2022

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Sio Gene Therapies Inc. quarterly Current Ratio history and growth rate from Q4 2015 to Q4 2022.
  • Sio Gene Therapies Inc. Current Ratio for the quarter ending December 31, 2022 was 796 %, a 22.4% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q4 2022 796 -230 -22.4% Dec 31, 2022
Q3 2022 652 -561 -46.2% Sep 30, 2022
Q2 2022 693 -425 -38% Jun 30, 2022
Q1 2022 846 -8.37 -0.98% Mar 31, 2022
Q4 2021 1.03K +531 +107% Dec 31, 2021
Q3 2021 1.21K +919 +313% Sep 30, 2021
Q2 2021 1.12K +917 +454% Jun 30, 2021
Q1 2021 855 +686 +405% Mar 31, 2021
Q4 2020 495 +320 +183% Dec 31, 2020
Q3 2020 294 +102 +53.2% Sep 30, 2020
Q2 2020 202 -3.83 -1.86% Jun 30, 2020
Q1 2020 169 -54 -24.2% Mar 31, 2020
Q4 2019 175 -68.4 -28.1% Dec 31, 2019
Q3 2019 192 -111 -36.8% Sep 30, 2019
Q2 2019 206 -197 -48.9% Jun 30, 2019
Q1 2019 223 -276 -55.3% Mar 31, 2019
Q4 2018 243 -290 -54.4% Dec 31, 2018
Q3 2018 303 -245 -44.7% Sep 30, 2018
Q2 2018 402 -182 -31.1% Jun 30, 2018
Q1 2018 499 -199 -28.5% Mar 31, 2018
Q4 2017 534 -436 -45% Dec 31, 2017
Q3 2017 548 -847 -60.7% Sep 30, 2017
Q2 2017 584 -1.39K -70.5% Jun 30, 2017
Q1 2017 697 -1.96K -73.8% Mar 31, 2017
Q4 2016 970 -1.79K -64.9% Dec 31, 2016
Q3 2016 1.39K Sep 30, 2016
Q2 2016 1.98K Jun 30, 2016
Q1 2016 2.66K Mar 31, 2016
Q4 2015 2.76K Dec 31, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.